Capivasertib - Intermediate
Name of Intermediate: tert-butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
Name of API: Capivasertib
CAS No: 1236033-21-8
Our Capivasertib intermediates are developed to meet stringent global standards for Active Pharmaceutical Ingredients (APIs). Manufactured using advanced synthesis routes and precise quality control, they enable efficient, high-yield production of Capivasertib. With scalable and reproducible processes, we ensure consistent purity and stability from lab-scale development to commercial manufacturing. Each intermediate is optimized for process efficiency, regulatory compliance, and reliable performance in formulation. Partnering with SSPharma gives you access to high-quality Capivasertib intermediates that support faster development cycles, robust supply chains, and seamless transition from R&D to large-scale production — empowering innovation in diabetes therapeutics.
